January 28, 2018 - By Marguerite Chambers
Analysts expect Sierra Oncology, Inc. (NASDAQ:SRRA) to report $-0.20 EPS on March, 1.They anticipate $0.10 EPS change or 33.33% from last quarter’s $-0.3 EPS. After having $-0.19 EPS previously, Sierra Oncology, Inc.’s analysts see 5.26% EPS growth. The stock increased 5.85% or $0.19 during the last trading session, reaching $3.44. About 2.20M shares traded or 262.81% up from the average. Sierra Oncology, Inc. (NASDAQ:SRRA) has declined 77.65% since January 28, 2017 and is downtrending. It has underperformed by 94.35% the S&P500.
Diam Company Ltd increased Zoetis Inc (ZTS) stake by 1.3% reported in 2017Q3 SEC filing. Diam Company Ltd acquired 10,111 shares as Zoetis Inc (ZTS)’s stock rose 14.85%. The Diam Company Ltd holds 787,171 shares with $50.17 million value, up from 777,060 last quarter. Zoetis Inc now has $39.03B valuation. The stock increased 1.06% or $0.84 during the last trading session, reaching $80.09. About 2.53 million shares traded or 4.20% up from the average. Zoetis Inc. (NYSE:ZTS) has risen 29.89% since January 28, 2017 and is uptrending. It has outperformed by 13.19% the S&P500.
Diam Company Ltd decreased Fortive Corp stake by 82,481 shares to 526,286 valued at $37.23M in 2017Q3. It also reduced Hartford Finl Svcs Group Inc (NYSE:HIG) stake by 17,276 shares and now owns 605,244 shares. Western Digital Corp (NASDAQ:WDC) was reduced too.
Among 21 analysts covering Zoetis Inc (NYSE:ZTS), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Zoetis Inc had 69 analyst reports since July 24, 2015 according to SRatingsIntel. On Tuesday, January 2 the stock rating was maintained by Craig Hallum with “Buy”. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, July 20. Jefferies maintained Zoetis Inc. (NYSE:ZTS) on Friday, June 16 with “Buy” rating. The stock of Zoetis Inc. (NYSE:ZTS) earned “Market Perform” rating by BMO Capital Markets on Tuesday, June 13. BMO Capital Markets upgraded the stock to “Outperform” rating in Friday, September 11 report. The firm earned “Buy” rating on Monday, July 17 by Cowen & Co. As per Wednesday, June 1, the company rating was initiated by Stifel Nicolaus. The stock of Zoetis Inc. (NYSE:ZTS) earned “Buy” rating by Bank of America on Thursday, September 29. Jefferies maintained the shares of ZTS in report on Tuesday, June 14 with “Buy” rating. As per Thursday, December 15, the company rating was upgraded by Cowen & Co.
Investors sentiment increased to 1.1 in 2017 Q3. Its up 0.06, from 1.04 in 2017Q2. It is positive, as 41 investors sold ZTS shares while 233 reduced holdings. 62 funds opened positions while 240 raised stakes. 440.74 million shares or 0.80% less from 444.27 million shares in 2017Q2 were reported. First Bancorporation Of Omaha stated it has 166,383 shares. Brown Advisory invested 1.49% in Zoetis Inc. (NYSE:ZTS). Loomis Sayles And LP has invested 0.03% in Zoetis Inc. (NYSE:ZTS). Echo Street Cap reported 131,934 shares or 0.29% of all its holdings. Schwab Charles Investment Mngmt holds 0.09% in Zoetis Inc. (NYSE:ZTS) or 1.63M shares. Bb&T Ltd Liability Corp invested 0.03% of its portfolio in Zoetis Inc. (NYSE:ZTS). Jnba Advsrs owns 27 shares. Ardevora Asset Management Limited Liability Partnership accumulated 426,600 shares or 0.81% of the stock. 85,795 are held by Natl Tx. Sandy Spring National Bank & Trust holds 0.19% in Zoetis Inc. (NYSE:ZTS) or 30,310 shares. Cipher LP reported 0.38% of its portfolio in Zoetis Inc. (NYSE:ZTS). Greystone Managed Invs stated it has 113,570 shares. Argent Trust Com stated it has 3,554 shares or 0.09% of all its holdings. Liberty Mutual Grp Asset Mgmt holds 19,875 shares or 0.07% of its portfolio. Fishman Jay A Mi reported 0.06% in Zoetis Inc. (NYSE:ZTS).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.